Back

Levosimendan therapy and mortality predictors in end-stage heart failure patients beyond advanced therapeutic options

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: In-hospital care of acute heart failure Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Santiago Jimenez-Marrero

University Hospital of Bellvitge, Barcelona (Spain)

7 More presentations in this session

Presentation thumbnail
Prognostic impact of urine output after catecholamine administration in cardiogenic shock due to acute decompensated heart failure
Doctor S. Kawanami (Sakai, JP)
Abstract Slides Video
Presentation thumbnail
Impact of in-hospital initiation of angiotensin receptor-neprilysin inhibition on left ventricular reverse remodeling in acute heart failure: an insight from PREMIER trial
Assistant Professor T. Takahashi (Tokushima, JP)
Abstract Slides Video
Presentation thumbnail
Impact and course of albuminuria in acute heart failure according to left or right sided heart failure phenotype
Mr J. Deniz Rosario (Las Palmas de Gran Canaria, ES)
Abstract Slides Video
Presentation thumbnail
Prognostic value of energetic hemodynamics in acute heart failure: beyond conventional measures
Doctor H. Chang (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Guideline directed medical treatment and comorbidity burden among patients admitted with acute HF decompensation: insights from the HECMOS 2.0
Doctor I. Leontsinis (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
In-hospital care of acute heart failure

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Intermittent levosimendan therapy and survival outcomes in advanced heart failure: insights from a real-world single-centre study
thumbnail
Congress Session
Acute heart failure II
thumbnail
Congress Session
Comorbidities and heart failure therapies

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources